欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (5): 617-622.doi: 10.12092/j.issn.1009-2501.2026.05.005

• 定量药理学 • 上一篇    下一篇

临床试验非计划样本量重估方法及其性能评价

王静怡1,3(), 熊航乐2,3, 刘玉秀1,2,3,*(), 倪咏天1,3, 李维勤3   

  1. 1. 南京医科大学公共卫生学院生物统计学系,南京 211166,江苏
    2. 南方医科大学公共卫生学院生物统计学系,广州 510515,广东
    3. 东部战区总医院重症医学科,南京 210002,江苏
  • 收稿日期:2025-09-16 修回日期:2025-10-22 出版日期:2026-05-26 发布日期:2026-06-02
  • 通讯作者: 刘玉秀 E-mail:Wangjy@stu.njmu.edu.cn;liu_yuxiu@163.com
  • 作者简介:王静怡,女,硕士研究生,研究方向:临床试验统计方法学研究及应用。E-mail:Wangjy@stu.njmu.edu.cn
  • 基金资助:
    国家自然科学基金面上项目(81473066)

Unplanned sample size re-estimation method and its performance evaluation in clinical trials

Jingyi WANG1,3(), Hangle XIONG2,3, Yuxiu LIU1,2,3,*(), Yongtian NI1,3, Weiqin LI3   

  1. 1. Department of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, China
    2. Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou 510515, Guangdong, China
    3. Department of Critical Care Medicine, General Hospital of Eastern Theater Command, Nanjing 210002, Jiangsu, China
  • Received:2025-09-16 Revised:2025-10-22 Online:2026-05-26 Published:2026-06-02
  • Contact: Yuxiu LIU E-mail:Wangjy@stu.njmu.edu.cn;liu_yuxiu@163.com

摘要:

目的: 临床试验中有时会受到外部临床试验结果影响,触发非计划的期中决策,通常包括提前终止和样本量重估。本文拟评价固定样本的临床试验中,非计划样本量重估方法的统计性能。方法: 在介绍非计划样本量重估的固定PP值法和Reoptimization法的基础上,通过设定不同的组间疗效真实值,将其与传统的CPZ法进行Monte-Carlo模拟比较研究,采用一类错误率、预测把握度、期望把握度、期望样本量和平均样本量评价其统计学性能。结果: 三种样本量重估方法的一类错误率均能较好保持在预设的水准,但唯有Reoptimization法能较好维持期望把握度。而且,在初始假定疗效等于或低于真实疗效时,相较固定PP值法,Reoptimization法所估计的样本量偏大;初始假定疗效高于真实疗效时,Reoptimization法所估计的样本量更小。结论: Reoptimization法具有较好的统计学性能,可推荐用于固定样本设计临床试验中非计划样本量重估。

关键词: 固定样本设计, 非计划样本量重估, 条件把握度, 条件误差原理

Abstract:

AIM: In clinical trials, external clinical trial results sometimes trigger unplanned interim decisions, which typically involve early termination and sample size re-estimation. This article aims to evaluate the statistical performance of unplanned sample size re-estimation methods in fixed-sample clinical trials. METHODS: Based on the introduction of unplanned sample size re-estimation methods, including the fixed PP method and the Reoptimization method, a Monte-Carlo simulation study was conducted by setting different true treatment effect between groups, and comparing them with the traditional CPZ method. Statistical performance was evaluated using the Type I error rate, prediction accuracy, expected power, expected sample size, and average sample size. RESULTS: The Type I error rates of the three sample size re-estimation methods were well maintained at the preset level, but only the Reoptimization method maintained the expected power. Furthermore, when the initial estimated treatment effect was equal to or lower than the true treatment effect, the sample size estimated by the Reoptimization method was larger than that of the fixed PP method. When the initial estimated treatment effect was higher than the true treatment effect, the sample size estimated by the Reoptimization method was smaller. CONCLUSION: The Reoptimization method demonstrates better statistical performance and is recommended for unplanned sample size re-estimation in fixed-sample design clinical trials.

Key words: fixed-sample design, unplanned sample size re-estimation, conditional power, conditional error principle

中图分类号: